Related Experiment Video

Updated: May 20, 2025

Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells
06:44

Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells

Published on: March 1, 2024

910

Molecular Dynamics Investigation into the Stability of KRas and CRaf Multimeric Complexes

Chongli Geng1, Juan Zeng2, Xianming Deng3,4

  • 1School of Chemistry and Molecular Engineering, NYU-ECNU Center for Computational Chemistry at NYU Shanghai, East China Normal University, Shanghai 200062, China.

The Journal of Physical Chemistry. B
|March 24, 2025
PubMed

Insights

Researchers explored the Ras/Raf/MAPK pathway, revealing stable KRas-CRaf complexes crucial for cell signaling. A specific binding site on KRas-CRaf was identified as a potential therapeutic target.

Area of Science:

  • Molecular biology
  • Cell signaling
  • Biophysics

Background:

  • The Ras/Raf/MAPK pathway regulates cell growth and differentiation.
  • Ras and Raf proteins form complexes, influencing signal transduction.
  • Aberrant signaling in this pathway is linked to diseases like cancer.

Purpose of the Study:

  • To investigate the structural stability of KRas-CRaf complexes.
  • To identify potential therapeutic targets within the Ras/Raf/MAPK pathway.

Main Methods:

  • Construction of ternary and quaternary KRas-CRaf complexes.
  • Molecular dynamics (MD) simulations.
  • Analysis of hydrogen bonds and salt bridges at protein-protein interfaces.

Main Results:

  • KRas-CRaf complexes exhibit significant stability in explicit solvent.
  • The quaternary complex (KRas)2·(CRaf)2 forms through the association of binary KRas-CRaf complexes.
  • A stable, extended binding site was identified at the KRas-CRaf interface.

Conclusions:

  • The KRas-CRaf complex is more stable than the KRas dimer.
  • The identified KRas-CRaf binding site represents a promising target for therapeutic intervention.
  • Blocking this site could inhibit aberrant signaling in the Ras/Raf/MAPK pathway.

More Related Videos

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.0K
Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

8.5K

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.0K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
3.9K